# Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

> **NCT06780397** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma, Stage II
- Melanoma Stage III
- Melanoma Stage IV

## Interventions

- **DIAGNOSTIC_TEST:** Joint ultrasonography
- **OTHER:** European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 version 3.0

## Key facts

- **NCT ID:** NCT06780397
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780397, "Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06780397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*